BIMINI Biotech: Funding, Investors & Team (Sep 2026)
BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking therapeutic approaches for oncology by targeting the growth hormone receptor (GHR) and its interaction with insulin-like growth factor 1 (IGF-1). The company also aims to address metabolic diseases and aging through its innovative strategies.
BIMINI Biotech has raised $3.1M across 1 funding round on record, the most recent a Seed of $3.1M announced in Jan 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BIMINI Biotech Company Profile and Key Stats
Latest funding round on record: Jan 2025.
BIMINI Biotech Funding Rounds
BIMINI Biotech Founders and Leadership Team
No contact details are on record for this team yet.
BIMINI Biotech Funding Compared to Other Biotechnology Startups
BIMINI Biotech's latest round of $3.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BIMINI Biotech in Biotechnology and Leiden
Companies Similar to BIMINI Biotech
The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…
Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and…
Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…
Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…
Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our…
Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…
We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…
QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.
Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…
QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…
Citryll is a private pharmaceutical company that develops pharmaceutical drugs used to treat autoimmune and…
BIMINI Biotech Funding FAQs
What does BIMINI Biotech do?
BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking therapeutic approaches for oncology by targeting the growth hormone receptor (GHR) and its interaction with insulin-like growth factor 1 (IGF-1). The company also aims to address metabolic diseases and aging through its innovative strategies.
How much funding has BIMINI Biotech raised?
BIMINI Biotech has raised $3.1M across 1 round on record. The most recent is a Seed of $3.1M announced in Jan 2025.
When did BIMINI Biotech last raise funding?
BIMINI Biotech's most recent funding round on record is a Seed of $3.1M, announced in Jan 2025.
Who founded BIMINI Biotech?
FundedIQ lists Francois Xavier Pellay (Founder) at BIMINI Biotech.
Where is BIMINI Biotech headquartered?
BIMINI Biotech is based in Leiden, Zuid-Holland, Netherlands.
How many employees does BIMINI Biotech have?
BIMINI Biotech is in the 1-10 employee band.
How does BIMINI Biotech's funding compare to other Biotechnology startups?
BIMINI Biotech's latest round of $3.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's BIMINI Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BIMINI Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.